お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、獣医・動物用ワクチンの世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に獣医・動物用ワクチン市場を分類しています。
本レポートでは世界の獣医・動物用ワクチン市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Zoetis、Merck Animal Health、Boehringer Ingelheim、Elanco、Virbac、Vetoquinol、Phibro Animal Health、Hester、Hipra、Idt Biologika、Biogenesis Bago、Tianjin Ringpu、China Animal Husbandry

レポートは獣医・動物用ワクチンの主要生産者を調査し、主要地域や国の消費状況も提供します。獣医・動物用ワクチンの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Live Attenuated Vaccines
    Inactivated Vaccines
    Toxoid Vaccines
    Recombinant Vaccines
    Other Vaccines

用途別の市場セグメント：
    Hospitals and Clinics
    Others

本レポートの詳細内容
本レポートは、世界の獣医・動物用ワクチン市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて獣医・動物用ワクチン市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）の獣医・動物用ワクチン生産量、成長率、市場シェアを調査している。

二. 消費面では、獣医・動物用ワクチンの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーの獣医・動物用ワクチン売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の獣医・動物用ワクチン市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本獣医・動物用ワクチンのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：獣医・動物用ワクチンのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： 獣医・動物用ワクチンの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおける獣医・動物用ワクチンの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章獣医・動物用ワクチンメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：獣医・動物用ワクチンの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：獣医・動物用ワクチンの主要メーカーの概要を提供し、製品の説明と仕様、獣医・動物用ワクチンの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：獣医・動物用ワクチンの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

The market is classified into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines and other vaccines on the basis of technology.

The global Veterinary & Animal Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 11%.
Report Covers:
This report presents an overview of global market for Veterinary & Animal Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Veterinary & Animal Vaccines, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Veterinary & Animal Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Veterinary & Animal Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Veterinary & Animal Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Veterinary & Animal Vaccines sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco, Virbac, Vetoquinol, Phibro Animal Health, Hester and Hipra, etc.

Market Segmentation
By Company
    Zoetis
    Merck Animal Health
    Boehringer Ingelheim
    Elanco
    Virbac
    Vetoquinol
    Phibro Animal Health
    Hester
    Hipra
    Idt Biologika
    Biogenesis Bago
    Tianjin Ringpu
    China Animal Husbandry

Segment by Type
    Live Attenuated Vaccines
    Inactivated Vaccines
    Toxoid Vaccines
    Recombinant Vaccines
    Other Vaccines

Segment by Application
    Hospitals and Clinics
    Others

Segment by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Veterinary & Animal Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Veterinary & Animal Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary & Animal Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
    Table 1. Global Veterinary & Animal Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Live Attenuated Vaccines
    Table 3. Major Manufacturers of Inactivated Vaccines
    Table 4. Major Manufacturers of Toxoid Vaccines
    Table 5. Major Manufacturers of Recombinant Vaccines
    Table 6. Major Manufacturers of Other Vaccines
    Table 7. Global Veterinary & Animal Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 8. Global Veterinary & Animal Vaccines Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 9. Global Veterinary & Animal Vaccines Revenue by Region (2019-2024) & (US$ Million)
    Table 10. Global Veterinary & Animal Vaccines Revenue by Region (2025-2030) & (US$ Million)
    Table 11. Global Veterinary & Animal Vaccines Revenue Market Share by Region (2019-2024)
    Table 12. Global Veterinary & Animal Vaccines Revenue Market Share by Region (2025-2030)
    Table 13. Global Veterinary & Animal Vaccines Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Veterinary & Animal Vaccines Sales by Region (2019-2024) & (K Units)
    Table 15. Global Veterinary & Animal Vaccines Sales by Region (2025-2030) & (K Units)
    Table 16. Global Veterinary & Animal Vaccines Sales Market Share by Region (2019-2024)
    Table 17. Global Veterinary & Animal Vaccines Sales Market Share by Region (2025-2030)
    Table 18. Global Veterinary & Animal Vaccines Sales by Manufacturers (2019-2024) & (K Units)
    Table 19. Global Veterinary & Animal Vaccines Sales Share by Manufacturers (2019-2024)
    Table 20. Global Veterinary & Animal Vaccines Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 21. Global Veterinary & Animal Vaccines Revenue Share by Manufacturers (2019-2024)
    Table 22. Global Key Players of Veterinary & Animal Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
    Table 23. Veterinary & Animal Vaccines Price by Manufacturers 2019-2024 (USD/Unit)
    Table 24. Global Veterinary & Animal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 25. Global Veterinary & Animal Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary & Animal Vaccines as of 2023)
    Table 26. Global Key Manufacturers of Veterinary & Animal Vaccines, Manufacturing Base Distribution and Headquarters
    Table 27. Global Key Manufacturers of Veterinary & Animal Vaccines, Product Offered and Application
    Table 28. Global Key Manufacturers of Veterinary & Animal Vaccines, Date of Enter into This Industry
    Table 29. Mergers & Acquisitions, Expansion Plans
    Table 30. Global Veterinary & Animal Vaccines Sales by Type (2019-2024) & (K Units)
    Table 31. Global Veterinary & Animal Vaccines Sales by Type (2025-2030) & (K Units)
    Table 32. Global Veterinary & Animal Vaccines Sales Share by Type (2019-2024)
    Table 33. Global Veterinary & Animal Vaccines Sales Share by Type (2025-2030)
    Table 34. Global Veterinary & Animal Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 35. Global Veterinary & Animal Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 36. Global Veterinary & Animal Vaccines Revenue Share by Type (2019-2024)
    Table 37. Global Veterinary & Animal Vaccines Revenue Share by Type (2025-2030)
    Table 38. Veterinary & Animal Vaccines Price by Type (2019-2024) & (USD/Unit)
    Table 39. Global Veterinary & Animal Vaccines Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 40. Global Veterinary & Animal Vaccines Sales by Application (2019-2024) & (K Units)
    Table 41. Global Veterinary & Animal Vaccines Sales by Application (2025-2030) & (K Units)
    Table 42. Global Veterinary & Animal Vaccines Sales Share by Application (2019-2024)
    Table 43. Global Veterinary & Animal Vaccines Sales Share by Application (2025-2030)
    Table 44. Global Veterinary & Animal Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 45. Global Veterinary & Animal Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 46. Global Veterinary & Animal Vaccines Revenue Share by Application (2019-2024)
    Table 47. Global Veterinary & Animal Vaccines Revenue Share by Application (2025-2030)
    Table 48. Veterinary & Animal Vaccines Price by Application (2019-2024) & (USD/Unit)
    Table 49. Global Veterinary & Animal Vaccines Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 50. US & Canada Veterinary & Animal Vaccines Sales by Type (2019-2024) & (K Units)
    Table 51. US & Canada Veterinary & Animal Vaccines Sales by Type (2025-2030) & (K Units)
    Table 52. US & Canada Veterinary & Animal Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 53. US & Canada Veterinary & Animal Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 54. US & Canada Veterinary & Animal Vaccines Sales by Application (2019-2024) & (K Units)
    Table 55. US & Canada Veterinary & Animal Vaccines Sales by Application (2025-2030) & (K Units)
    Table 56. US & Canada Veterinary & Animal Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 57. US & Canada Veterinary & Animal Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 58. US & Canada Veterinary & Animal Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 59. US & Canada Veterinary & Animal Vaccines Revenue by Country (2019-2024) & (US$ Million)
    Table 60. US & Canada Veterinary & Animal Vaccines Revenue by Country (2025-2030) & (US$ Million)
    Table 61. US & Canada Veterinary & Animal Vaccines Sales by Country (2019-2024) & (K Units)
    Table 62. US & Canada Veterinary & Animal Vaccines Sales by Country (2025-2030) & (K Units)
    Table 63. Europe Veterinary & Animal Vaccines Sales by Type (2019-2024) & (K Units)
    Table 64. Europe Veterinary & Animal Vaccines Sales by Type (2025-2030) & (K Units)
    Table 65. Europe Veterinary & Animal Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 66. Europe Veterinary & Animal Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 67. Europe Veterinary & Animal Vaccines Sales by Application (2019-2024) & (K Units)
    Table 68. Europe Veterinary & Animal Vaccines Sales by Application (2025-2030) & (K Units)
    Table 69. Europe Veterinary & Animal Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 70. Europe Veterinary & Animal Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 71. Europe Veterinary & Animal Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 72. Europe Veterinary & Animal Vaccines Revenue by Country (2019-2024) & (US$ Million)
    Table 73. Europe Veterinary & Animal Vaccines Revenue by Country (2025-2030) & (US$ Million)
    Table 74. Europe Veterinary & Animal Vaccines Sales by Country (2019-2024) & (K Units)
    Table 75. Europe Veterinary & Animal Vaccines Sales by Country (2025-2030) & (K Units)
    Table 76. China Veterinary & Animal Vaccines Sales by Type (2019-2024) & (K Units)
    Table 77. China Veterinary & Animal Vaccines Sales by Type (2025-2030) & (K Units)
    Table 78. China Veterinary & Animal Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 79. China Veterinary & Animal Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 80. China Veterinary & Animal Vaccines Sales by Application (2019-2024) & (K Units)
    Table 81. China Veterinary & Animal Vaccines Sales by Application (2025-2030) & (K Units)
    Table 82. China Veterinary & Animal Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 83. China Veterinary & Animal Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 84. Asia Veterinary & Animal Vaccines Sales by Type (2019-2024) & (K Units)
    Table 85. Asia Veterinary & Animal Vaccines Sales by Type (2025-2030) & (K Units)
    Table 86. Asia Veterinary & Animal Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 87. Asia Veterinary & Animal Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 88. Asia Veterinary & Animal Vaccines Sales by Application (2019-2024) & (K Units)
    Table 89. Asia Veterinary & Animal Vaccines Sales by Application (2025-2030) & (K Units)
    Table 90. Asia Veterinary & Animal Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 91. Asia Veterinary & Animal Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 92. Asia Veterinary & Animal Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 93. Asia Veterinary & Animal Vaccines Revenue by Region (2019-2024) & (US$ Million)
    Table 94. Asia Veterinary & Animal Vaccines Revenue by Region (2025-2030) & (US$ Million)
    Table 95. Asia Veterinary & Animal Vaccines Sales by Region (2019-2024) & (K Units)
    Table 96. Asia Veterinary & Animal Vaccines Sales by Region (2025-2030) & (K Units)
    Table 97. Middle East, Africa and Latin America Veterinary & Animal Vaccines Sales by Type (2019-2024) & (K Units)
    Table 98. Middle East, Africa and Latin America Veterinary & Animal Vaccines Sales by Type (2025-2030) & (K Units)
    Table 99. Middle East, Africa and Latin America Veterinary & Animal Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 100. Middle East, Africa and Latin America Veterinary & Animal Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Veterinary & Animal Vaccines Sales by Application (2019-2024) & (K Units)
    Table 102. Middle East, Africa and Latin America Veterinary & Animal Vaccines Sales by Application (2025-2030) & (K Units)
    Table 103. Middle East, Africa and Latin America Veterinary & Animal Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Veterinary & Animal Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Veterinary & Animal Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 106. Middle East, Africa and Latin America Veterinary & Animal Vaccines Revenue by Country (2019-2024) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Veterinary & Animal Vaccines Revenue by Country (2025-2030) & (US$ Million)
    Table 108. Middle East, Africa and Latin America Veterinary & Animal Vaccines Sales by Country (2019-2024) & (K Units)
    Table 109. Middle East, Africa and Latin America Veterinary & Animal Vaccines Sales by Country (2025-2030) & (K Units)
    Table 110. Zoetis Company Information
    Table 111. Zoetis Description and Major Businesses
    Table 112. Zoetis Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. Zoetis Veterinary & Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Zoetis Recent Developments
    Table 115. Merck Animal Health Company Information
    Table 116. Merck Animal Health Description and Major Businesses
    Table 117. Merck Animal Health Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 118. Merck Animal Health Veterinary & Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Merck Animal Health Recent Developments
    Table 120. Boehringer Ingelheim Company Information
    Table 121. Boehringer Ingelheim Description and Major Businesses
    Table 122. Boehringer Ingelheim Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 123. Boehringer Ingelheim Veterinary & Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Boehringer Ingelheim Recent Developments
    Table 125. Elanco Company Information
    Table 126. Elanco Description and Major Businesses
    Table 127. Elanco Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 128. Elanco Veterinary & Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Elanco Recent Developments
    Table 130. Virbac Company Information
    Table 131. Virbac Description and Major Businesses
    Table 132. Virbac Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 133. Virbac Veterinary & Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Virbac Recent Developments
    Table 135. Vetoquinol Company Information
    Table 136. Vetoquinol Description and Major Businesses
    Table 137. Vetoquinol Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 138. Vetoquinol Veterinary & Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Vetoquinol Recent Developments
    Table 140. Phibro Animal Health Company Information
    Table 141. Phibro Animal Health Description and Major Businesses
    Table 142. Phibro Animal Health Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 143. Phibro Animal Health Veterinary & Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Phibro Animal Health Recent Developments
    Table 145. Hester Company Information
    Table 146. Hester Description and Major Businesses
    Table 147. Hester Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 148. Hester Veterinary & Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Hester Recent Developments
    Table 150. Hipra Company Information
    Table 151. Hipra Description and Major Businesses
    Table 152. Hipra Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 153. Hipra Veterinary & Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Hipra Recent Developments
    Table 155. Idt Biologika Company Information
    Table 156. Idt Biologika Description and Major Businesses
    Table 157. Idt Biologika Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 158. Idt Biologika Veterinary & Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Idt Biologika Recent Developments
    Table 160. Biogenesis Bago Company Information
    Table 161. Biogenesis Bago Description and Major Businesses
    Table 162. Biogenesis Bago Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 163. Biogenesis Bago Veterinary & Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Biogenesis Bago Recent Developments
    Table 165. Tianjin Ringpu Company Information
    Table 166. Tianjin Ringpu Description and Major Businesses
    Table 167. Tianjin Ringpu Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 168. Tianjin Ringpu Veterinary & Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Tianjin Ringpu Recent Developments
    Table 170. China Animal Husbandry Company Information
    Table 171. China Animal Husbandry Description and Major Businesses
    Table 172. China Animal Husbandry Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 173. China Animal Husbandry Veterinary & Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 174. China Animal Husbandry Recent Developments
    Table 175. Key Raw Materials Lists
    Table 176. Raw Materials Key Suppliers Lists
    Table 177. Veterinary & Animal Vaccines Distributors List
    Table 178. Veterinary & Animal Vaccines Customers List
    Table 179. Veterinary & Animal Vaccines Market Trends
    Table 180. Veterinary & Animal Vaccines Market Drivers
    Table 181. Veterinary & Animal Vaccines Market Challenges
    Table 182. Veterinary & Animal Vaccines Market Restraints
    Table 183. Research Programs/Design for This Report
    Table 184. Key Data Information from Secondary Sources
    Table 185. Key Data Information from Primary Sources
List of Figures
    Figure 1. Veterinary & Animal Vaccines Product Picture
    Figure 2. Global Veterinary & Animal Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Veterinary & Animal Vaccines Market Share by Type in 2023 & 2030
    Figure 4. Live Attenuated Vaccines Product Picture
    Figure 5. Inactivated Vaccines Product Picture
    Figure 6. Toxoid Vaccines Product Picture
    Figure 7. Recombinant Vaccines Product Picture
    Figure 8. Other Vaccines Product Picture
    Figure 9. Global Veterinary & Animal Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 10. Global Veterinary & Animal Vaccines Market Share by Application in 2023 & 2030
    Figure 11. Hospitals and Clinics
    Figure 12. Others
    Figure 13. Veterinary & Animal Vaccines Report Years Considered
    Figure 14. Global Veterinary & Animal Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Veterinary & Animal Vaccines Revenue 2019-2030 (US$ Million)
    Figure 16. Global Veterinary & Animal Vaccines Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 17. Global Veterinary & Animal Vaccines Revenue Market Share by Region (2019-2030)
    Figure 18. Global Veterinary & Animal Vaccines Sales 2019-2030 ((K Units)
    Figure 19. Global Veterinary & Animal Vaccines Sales Market Share by Region (2019-2030)
    Figure 20. US & Canada Veterinary & Animal Vaccines Sales YoY (2019-2030) & (K Units)
    Figure 21. US & Canada Veterinary & Animal Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. Europe Veterinary & Animal Vaccines Sales YoY (2019-2030) & (K Units)
    Figure 23. Europe Veterinary & Animal Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. China Veterinary & Animal Vaccines Sales YoY (2019-2030) & (K Units)
    Figure 25. China Veterinary & Animal Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Asia (excluding China) Veterinary & Animal Vaccines Sales YoY (2019-2030) & (K Units)
    Figure 27. Asia (excluding China) Veterinary & Animal Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. Middle East, Africa and Latin America Veterinary & Animal Vaccines Sales YoY (2019-2030) & (K Units)
    Figure 29. Middle East, Africa and Latin America Veterinary & Animal Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 30. The Veterinary & Animal Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 31. The Top 5 and 10 Largest Manufacturers of Veterinary & Animal Vaccines in the World: Market Share by Veterinary & Animal Vaccines Revenue in 2023
    Figure 32. Global Veterinary & Animal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 33. Global Veterinary & Animal Vaccines Sales Market Share by Type (2019-2030)
    Figure 34. Global Veterinary & Animal Vaccines Revenue Market Share by Type (2019-2030)
    Figure 35. Global Veterinary & Animal Vaccines Sales Market Share by Application (2019-2030)
    Figure 36. Global Veterinary & Animal Vaccines Revenue Market Share by Application (2019-2030)
    Figure 37. US & Canada Veterinary & Animal Vaccines Sales Market Share by Type (2019-2030)
    Figure 38. US & Canada Veterinary & Animal Vaccines Revenue Market Share by Type (2019-2030)
    Figure 39. US & Canada Veterinary & Animal Vaccines Sales Market Share by Application (2019-2030)
    Figure 40. US & Canada Veterinary & Animal Vaccines Revenue Market Share by Application (2019-2030)
    Figure 41. US & Canada Veterinary & Animal Vaccines Revenue Share by Country (2019-2030)
    Figure 42. US & Canada Veterinary & Animal Vaccines Sales Share by Country (2019-2030)
    Figure 43. U.S. Veterinary & Animal Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 44. Canada Veterinary & Animal Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 45. Europe Veterinary & Animal Vaccines Sales Market Share by Type (2019-2030)
    Figure 46. Europe Veterinary & Animal Vaccines Revenue Market Share by Type (2019-2030)
    Figure 47. Europe Veterinary & Animal Vaccines Sales Market Share by Application (2019-2030)
    Figure 48. Europe Veterinary & Animal Vaccines Revenue Market Share by Application (2019-2030)
    Figure 49. Europe Veterinary & Animal Vaccines Revenue Share by Country (2019-2030)
    Figure 50. Europe Veterinary & Animal Vaccines Sales Share by Country (2019-2030)
    Figure 51. Germany Veterinary & Animal Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 52. France Veterinary & Animal Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 53. U.K. Veterinary & Animal Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 54. Italy Veterinary & Animal Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 55. Russia Veterinary & Animal Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 56. China Veterinary & Animal Vaccines Sales Market Share by Type (2019-2030)
    Figure 57. China Veterinary & Animal Vaccines Revenue Market Share by Type (2019-2030)
    Figure 58. China Veterinary & Animal Vaccines Sales Market Share by Application (2019-2030)
    Figure 59. China Veterinary & Animal Vaccines Revenue Market Share by Application (2019-2030)
    Figure 60. Asia Veterinary & Animal Vaccines Sales Market Share by Type (2019-2030)
    Figure 61. Asia Veterinary & Animal Vaccines Revenue Market Share by Type (2019-2030)
    Figure 62. Asia Veterinary & Animal Vaccines Sales Market Share by Application (2019-2030)
    Figure 63. Asia Veterinary & Animal Vaccines Revenue Market Share by Application (2019-2030)
    Figure 64. Asia Veterinary & Animal Vaccines Revenue Share by Region (2019-2030)
    Figure 65. Asia Veterinary & Animal Vaccines Sales Share by Region (2019-2030)
    Figure 66. Japan Veterinary & Animal Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 67. South Korea Veterinary & Animal Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 68. China Taiwan Veterinary & Animal Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 69. Southeast Asia Veterinary & Animal Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 70. India Veterinary & Animal Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 71. Middle East, Africa and Latin America Veterinary & Animal Vaccines Sales Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Veterinary & Animal Vaccines Revenue Market Share by Type (2019-2030)
    Figure 73. Middle East, Africa and Latin America Veterinary & Animal Vaccines Sales Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Veterinary & Animal Vaccines Revenue Market Share by Application (2019-2030)
    Figure 75. Middle East, Africa and Latin America Veterinary & Animal Vaccines Revenue Share by Country (2019-2030)
    Figure 76. Middle East, Africa and Latin America Veterinary & Animal Vaccines Sales Share by Country (2019-2030)
    Figure 77. Brazil Veterinary & Animal Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 78. Mexico Veterinary & Animal Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 79. Turkey Veterinary & Animal Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 80. Israel Veterinary & Animal Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 81. GCC Countries Veterinary & Animal Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 82. Veterinary & Animal Vaccines Value Chain
    Figure 83. Veterinary & Animal Vaccines Production Process
    Figure 84. Channels of Distribution
    Figure 85. Distributors Profiles
    Figure 86. Bottom-up and Top-down Approaches for This Report
    Figure 87. Data Triangulation
    Figure 88. Key Executives Interviewed